News & Events
For media inquiries email [email protected]
Company news
April 25, 2025
Press Release
Parabilis Medicines Reports Positive Proof-of-Mechanism Data for Groundbreaking ERG Degrader Program
April 23, 2025
Press Release
Parabilis Medicines to Present First Preclinical Data on ERG Degrader Program at AACR Annual Meeting
Publications and presentations
March 5, 2024
Nature Communications
Mirror-image ligand discovery enabled by single-shot fast-flow synthesis of D-proteins
November 20, 2023
Nature Communications
Recognition and reprogramming of E3 ubiquitin ligase surfaces by α-helical peptides
December 19, 2022
PNAS
De novo mapping of α-helix recognition sites on protein surfaces using unbiased libraries
Recent highlights
November 4, 2024
Virtual
Truist Tru-Talks with Parabilis Medicines
Parabilis CEO Mathai Mammen joined Kripa Devarakonda at Truist for a discussion about our Helicon discovery platform, our pipeline of investigational medicines, and our ongoing clinical trial of FOG-001. Click to view the recorded webcast. (Registration required; list Kripa Devarakonda as Truist representative.)
Upcoming events
May 30, 2025
Chicago